ENDRA Life Sciences (NDRA) Operating Leases (2019 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Operating Leases of $327253.0 for Q1 2026, down 44.28% year-over-year from $587303.0 in Q1 2025, and down 9.84% quarter-over-quarter from $362974.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Operating Leases (2019 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Operating Leases for 8 consecutive years, with $327253.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Leases fell 44.28% year-over-year to $327253.0; the TTM figure through Mar 2026 stood at $327253.0 (down 44.28% YoY), while the FY2025 annual figure was $362974.0, down 25.54% from the prior year.
- Operating Leases slipped to $327253.0 in Q1 2026 per NDRA's latest filing, from $362974.0 in the prior quarter.
- Across five years, Operating Leases topped out at $618735.0 in Q1 2022 and bottomed at $49823.0 in Q3 2024.
- Historically, Operating Leases has averaged $410487.1 across 5 years, with a median of $405773.0 in 2023.
- Annual changes were most pronounced in 2024 — Operating Leases slumped 87.72% — and 2025, when it surged 954.39%.
- ENDRA Life Sciences' Operating Leases stood at $365919.0 in 2022, then changed by 0.0% to $365919.0 in 2023, then soared by 33.22% to $487482.0 in 2024, then slipped by 25.54% to $362974.0 in 2025, then dropped by 9.84% to $327253.0 in 2026.
- Business Quant data shows NDRA's Operating Leases at $327253.0 in Q1 2026, $362974.0 in Q4 2025, and $525328.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | ENDRA Life Sciences | 7.16 Mn | 1.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 290,630.00 |
| Mar 31, 2026 | 327,253.00 |
| Dec 31, 2025 | 362,974.00 |
| Sep 30, 2025 | 525,328.00 |
| Jun 30, 2025 | 557,492.00 |
| Mar 31, 2025 | 587,303.00 |
| Dec 31, 2024 | 584,419.00 |
| Sep 30, 2024 | 237,163.00 |
| Jun 30, 2024 | 281,154.00 |
| Mar 31, 2024 | 324,064.00 |
| Dec 31, 2023 | 365,919.00 |
| Sep 30, 2023 | 405,773.00 |
| Jun 30, 2023 | 444,167.00 |
| Mar 31, 2023 | 481,618.00 |
| Dec 31, 2022 | 518,147.00 |
| Sep 30, 2022 | 552,830.00 |
| Jun 30, 2022 | 586,193.00 |
| Mar 31, 2022 | 618,735.00 |
| Dec 31, 2021 | 650,477.00 |
| Sep 30, 2021 | 680,526.00 |